Humacyte (HUMA) Revenue & Revenue Breakdown
Humacyte Revenue Highlights
Humacyte Revenue by Period
Humacyte Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $1.56M | 23.91% |
| 2021-12-31 | $1.26M | -15.29% |
| 2020-12-31 | $1.49M | -75.90% |
| 2019-12-31 | $6.19M | - |
Humacyte generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Humacyte Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.79M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $31.00K | -97.62% |
| 2022-06-30 | $1.30M | 458.37% |
| 2022-03-31 | $233.00K | 31.64% |
| 2021-12-31 | $177.00K | -26.56% |
| 2021-09-30 | $241.00K | -65.07% |
| 2021-06-30 | $690.00K | 345.16% |
| 2021-03-31 | $155.00K | 25.00% |
| 2020-12-31 | $124.00K | -86.43% |
| 2020-09-30 | $914.00K | 361.62% |
| 2020-06-30 | $198.00K | -22.35% |
| 2020-03-31 | $255.00K | - |
Humacyte generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Humacyte Revenue Breakdown
Humacyte Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Humacyte's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Humacyte's latest quarterly revenue breakdown by geography, as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IMCR | Immunocore | $249.43M | $75.40M |
| MIRM | Mirum Pharmaceuticals | $186.37M | $69.22M |
| NRIX | Nurix Therapeutics | $76.99M | $12.59M |
| SEER | Seer | $16.66M | $3.07M |
| CYTK | Cytokinetics | $7.53M | $249.00K |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| HCWB | HCW Biologics | $2.84M | $618.85K |
| LYRA | Lyra Therapeutics | $1.56M | $598.00K |
| QSI | Quantum-Si | $1.08M | $457.00K |
| MNOV | MediciNova | $1.00M | - |
| VRDN | Viridian Therapeutics | $314.00K | $72.00K |
| GPCR | Structure Therapeutics | - | - |
| KURA | Kura Oncology | - | - |
| LRMR | Larimar Therapeutics | - | - |
| KALV | KalVista Pharmaceuticals | - | - |
| HUMA | Humacyte | - | - |
HUMA Revenue FAQ
What is Humacyte’s yearly revenue?
Humacyte's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $1.56M, representing an increase of 23.91% compared to 2021. HUMA's yearly revenue for 2021 was $1.26M, representing a decrease of -15.29% compared to 2020.
What is Humacyte’s quarterly revenue?
Humacyte's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). HUMA's quarterly revenue for Q4 2023 was $10.79M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Humacyte’s revenue growth rate?
Humacyte's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.